- Home
- GRWG vs NVNO Comparison
GRWG vs NVNO Comparison
Compare GRWG & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- NVNO
- Stock Information
- Founded
- GRWG 2008
- NVNO 1987
- Country
- GRWG United States
- NVNO United States
- Employees
- GRWG N/A
- NVNO N/A
- Industry
- GRWG RETAIL: Building Materials
- NVNO Medical/Dental Instruments
- Sector
- GRWG Consumer Discretionary
- NVNO Health Care
- Exchange
- GRWG Nasdaq
- NVNO Nasdaq
- Market Cap
- GRWG 98.0M
- NVNO 96.0M
- IPO Year
- GRWG N/A
- NVNO N/A
- Fundamental
- Price
- GRWG $1.77
- NVNO $1.00
- Analyst Decision
- GRWG Strong Buy
- NVNO
- Analyst Count
- GRWG 1
- NVNO 0
- Target Price
- GRWG $2.50
- NVNO N/A
- AVG Volume (30 Days)
- GRWG 882.7K
- NVNO 1.4M
- Earning Date
- GRWG 08-11-2025
- NVNO 07-31-2025
- Dividend Yield
- GRWG N/A
- NVNO N/A
- EPS Growth
- GRWG N/A
- NVNO N/A
- EPS
- GRWG N/A
- NVNO N/A
- Revenue
- GRWG $164,108,000.00
- NVNO N/A
- Revenue This Year
- GRWG N/A
- NVNO N/A
- Revenue Next Year
- GRWG N/A
- NVNO N/A
- P/E Ratio
- GRWG N/A
- NVNO N/A
- Revenue Growth
- GRWG N/A
- NVNO N/A
- 52 Week Low
- GRWG $0.82
- NVNO $0.90
- 52 Week High
- GRWG $2.33
- NVNO $5.70
- Technical
- Relative Strength Index (RSI)
- GRWG 77.17
- NVNO 18.49
- Support Level
- GRWG $1.45
- NVNO $0.90
- Resistance Level
- GRWG $1.64
- NVNO $5.09
- Average True Range (ATR)
- GRWG 0.13
- NVNO 0.37
- MACD
- GRWG 0.05
- NVNO -0.46
- Stochastic Oscillator
- GRWG 97.47
- NVNO 2.36
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.